These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5703765)

  • 41. Considerations on the use of sulphones and sulphonamides with a pyrimidine derivative.
    Botelho A
    S Afr Med J; 1974 Jun; 48(31):1351-2. PubMed ID: 4602988
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasmodium berghei: combining folic acid antagonists for potentiation against malaria infections in mice.
    Kinnamon KE; Ager AL; Orchard RW
    Exp Parasitol; 1976 Aug; 40(1):95-102. PubMed ID: 780121
    [No Abstract]   [Full Text] [Related]  

  • 43. The evaluation of quinine alone or in combination with tetracycline and pyrimethamine against falciparum malaria in Thailand.
    Chin W; Intraprasert R
    Southeast Asian J Trop Med Public Health; 1973 Jun; 4(2):245-9. PubMed ID: 4584107
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasmodium berghei: efficacy of 5-fluoroorotate in combination with commonly used antimalarial drugs in a mouse model.
    Muregi FW; Kano S; Kino H; Ishih A
    Exp Parasitol; 2009 Apr; 121(4):376-80. PubMed ID: 19271282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.
    Peters W; Robinson BL
    Ann Trop Med Parasitol; 1984 Oct; 78(5):459-66. PubMed ID: 6395814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic recombination in Plasmodium berghei.
    Walliker D; Carter R; Morgan S
    Parasitology; 1973 Apr; 66(2):309-20. PubMed ID: 4595115
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of pyrimethamine resistance on sporogony in a Plasmodium berghei/Anopheles stephensi model.
    Shinondo CJ; Lanners HN; Lowrie RC; Wiser MF
    Exp Parasitol; 1994 Mar; 78(2):194-202. PubMed ID: 8119374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined therapy for chloroquine-resistant, Plasmodium falciparum infection. Concurrent use of long-acting sulphormethoxine and pyrimethamine.
    Bartelloni PJ; Sheehy TW; Tigertt WD
    JAMA; 1967 Jan; 199(3):173-7. PubMed ID: 6071170
    [No Abstract]   [Full Text] [Related]  

  • 49. The chemotherapy of rodent malaria. XII. Substituted tetrahydrofurans, a new chemical family of antimalarials. The action of 2-(p-chlorophenyl)-2-(4-piperidyl)-tetrahydrofuran against Plasmodium berghei and Plasmodium chabaudi.
    Peters W
    Ann Trop Med Parasitol; 1970 Jun; 64(2):189-202. PubMed ID: 5497391
    [No Abstract]   [Full Text] [Related]  

  • 50. Quantitative aspects of pyrimethamine-sulfonamide synergism.
    Schmidt LH; Harrison J; Rossan RN; Vaughan D; Crosby R
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):837-49. PubMed ID: 410317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Plasmodium falciparum malaria in Cameroon with a single dose of antifolic drugs. 1. Combination of sulfametopyrazine and pyrimethamine.
    Catarinella G; Donno L
    J Trop Med Hyg; 1971 Nov; 74(11):243-6. PubMed ID: 4942346
    [No Abstract]   [Full Text] [Related]  

  • 52. Antimalarial effects of sulphormethoxine, diaphenylsulphone and separate combinations of these with pyrimethamine: a review of preliminary investigations carried out in Tanzania.
    Laing AB
    J Trop Med Hyg; 1968 Feb; 71(2):27-35. PubMed ID: 4867507
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative study of a single dose of the pyrimethamine-sulfametopyrazine combination and chloroquine in the treatment of malaria attacks caused by Plasmodium falciparum in semi-immune patients in endemic areas (study carried out in Bobo-Dioulasso, Upper Volta)].
    Picq JJ; Charmot G; Ricosse JH
    Med Trop (Mars); 1972; 32(4):527-46. PubMed ID: 4675015
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of chloroquine-resistant Plasmodium falciparum infections in Vietnam.
    Sheehy TW; Reba RC
    Ann Intern Med; 1967 Mar; 66(3):616-22. PubMed ID: 6019938
    [No Abstract]   [Full Text] [Related]  

  • 55. ROLE OF P-AMINOBENZOIC ACID IN PLASMODIUM BERGHEI INFECTION IN THE MOUSE.
    JACOBS RL
    Exp Parasitol; 1964 Jun; 15():213-25. PubMed ID: 14191322
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasmodium berghei: routine production of pure gametocytes, extracellular gametes, zygotes, and ookinetes.
    Rodríguez MC; Margos G; Compton H; Ku M; Lanz H; Rodríguez MH; Sinden RE
    Exp Parasitol; 2002 May; 101(1):73-6. PubMed ID: 12243741
    [No Abstract]   [Full Text] [Related]  

  • 57. The chemotherapy of rodent malaria. VII. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites, 2: schizontocidal action in the albino mouse.
    Peters W
    Annu Rev Pharmacol; 1968 Dec; 62(4):488-94. PubMed ID: 5731727
    [No Abstract]   [Full Text] [Related]  

  • 58. [Combined action of pyronaridine and sulfadoxine/pyrimethamine against Plasmodium berghei ANKA strain in mice].
    Shi XH; Shao BR; Ye XY
    Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):66-9. PubMed ID: 2206014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Host failure in treatment of malaria with sulfalene and pyrimethamine.
    Trenholme GM; Williams RL; Frischer H; Carson PE; Rieckmann KH
    Ann Intern Med; 1975 Feb; 82(2):219-23. PubMed ID: 1090224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chloroquine resistant P. falciparum malaria and its management.
    Choudhury DS
    Indian J Pediatr; 1985; 52(416):281-4. PubMed ID: 3910577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.